|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 35/74 | |
| A61P 25/04 | |||
| A61P 35/00 |
| (11) | Patento numeris | 2083837 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 07866446.3 |
| Europos patento paraiškos padavimo data | 2007-10-26 | |
| (97) | Europos patento paraiškos paskelbimo data | 2009-08-05 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2015-01-07 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/FR2007/001773 |
| Data | 2007-10-26 |
| (87) | Numeris | WO 2008/059126 |
| Data | 2008-05-22 |
| (30) | Numeris | Data | Šalis |
| 0609435 | 2006-10-27 | FR |
| (72) |
FAVRE, Christine, FR
AUGUET, Michel, FR
CHABRIER DE LASSAUNIERE, Pierre-Etienne, FR
|
| (73) |
IPSEN PHARMA S.A.S.,
65, Quai Georges Gorse, 92100 Boulogne-Billancourt,
FR
|
| (54) | UTILISATION THERAPEUTIQUE D`AU MOINS UNE NEUROTOXINE BOTULIQUE DANS LE TRAITEMENT DE LA DOULEUR INDUITE PAR AU MOINS UN AGENT ANTI-CANCEREUX |
| THERAPEUTIC USE OF AT LEAST ONE BOTULIC NEUROTOXIN IN THE TREATMENT OF PAIN INDUCED BY AT LEAST ONE ANTINEOPLASTIC AGENT |